You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Lung cancer

Plasma EGFR mutation tests for adults with locally advanced or metastatic non-small-cell lung cancer

  • Medtech innovation briefing
  • Reference number: MIB137
  • Published:  18 January 2018

Download (PDF)
  • Overview
  • Summary
  • The technologies
  • Regulatory information
  • Equality considerations
  • Clinical and technical evidence
  • Specialist commentator comments
  • Specialist commentators
  • Additional commentators
  • Development of this briefing

Overview

NICE has developed a medtech innovation briefing (MIB) on plasma EGFR mutation tests for adults with locally advanced or metastatic non-small-cell lung cancer.

What are MIBs?


Next page Summary
Back to top